METRNL
Basic information
Region (hg38): 17:83079609-83095122
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the METRNL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 26 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 5 | 4 |
Variants in METRNL
This is a list of pathogenic ClinVar variants found in the METRNL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-83079838-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
17-83079864-C-G | not specified | Likely benign (Apr 13, 2022) | ||
17-83079886-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
17-83079892-C-T | not specified | Uncertain significance (May 09, 2023) | ||
17-83079898-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
17-83079943-C-A | not specified | Uncertain significance (Jul 20, 2021) | ||
17-83084987-C-A | not specified | Uncertain significance (Dec 15, 2023) | ||
17-83084998-G-A | Benign (Apr 04, 2018) | |||
17-83085061-C-G | not specified | Uncertain significance (Nov 17, 2022) | ||
17-83085063-C-T | not specified | Uncertain significance (Nov 10, 2022) | ||
17-83085111-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
17-83085158-G-T | not specified | Uncertain significance (Jan 31, 2024) | ||
17-83085167-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
17-83085192-A-G | Benign (Jan 30, 2018) | |||
17-83085224-G-C | not specified | Uncertain significance (Jan 10, 2023) | ||
17-83085248-A-G | not specified | Uncertain significance (Jul 05, 2023) | ||
17-83085251-G-A | not specified | Likely benign (Apr 07, 2022) | ||
17-83085278-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
17-83085287-A-G | not specified | Uncertain significance (May 05, 2022) | ||
17-83085300-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
17-83093195-G-T | not specified | Uncertain significance (Jul 14, 2022) | ||
17-83093219-C-G | not specified | Uncertain significance (Apr 22, 2024) | ||
17-83094258-G-A | not specified | Uncertain significance (Sep 27, 2022) | ||
17-83094264-G-A | not specified | Uncertain significance (Jan 31, 2023) | ||
17-83094284-C-A | Benign (Jan 30, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
METRNL | protein_coding | protein_coding | ENST00000320095 | 4 | 15298 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.745 | 0.253 | 125344 | 0 | 5 | 125349 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.11 | 140 | 182 | 0.769 | 0.0000135 | 1962 |
Missense in Polyphen | 44 | 68.485 | 0.64247 | 750 | ||
Synonymous | -0.362 | 89 | 84.8 | 1.05 | 0.00000685 | 675 |
Loss of Function | 2.45 | 1 | 8.85 | 0.113 | 4.39e-7 | 111 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000179 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000179 | 0.000164 |
dbNSFP
Source:
- Function
- FUNCTION: Hormone induced following exercise or cold exposure that promotes energy expenditure. Induced either in the skeletal muscle after exercise or in adipose tissue following cold exposure and is present in the circulation. Able to stimulate energy expenditure associated with the browning of the white fat depots and improves glucose tolerance. Does not promote an increase in a thermogenic gene program via direct action on adipocytes, but acts by stimulating several immune cell subtypes to enter the adipose tissue and activate their prothermogenic actions. Stimulates an eosinophil-dependent increase in IL4 expression and promotes alternative activation of adipose tissue macrophages, which are required for the increased expression of the thermogenic and anti- inflammatory gene programs in fat. Required for some cold-induced thermogenic responses, suggesting a role in metabolic adaptations to cold temperatures (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.130
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.99
Haploinsufficiency Scores
- pHI
- 0.175
- hipred
- Y
- hipred_score
- 0.691
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0902
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Metrnl
- Phenotype
- skeleton phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- response to cold;regulation of signaling receptor activity;response to muscle activity;fat cell differentiation;negative regulation of inflammatory response;brown fat cell differentiation;positive regulation of brown fat cell differentiation;energy homeostasis
- Cellular component
- extracellular space;extracellular exosome
- Molecular function
- molecular_function;hormone activity